Form 4: Organogenesis Holdings CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Organogenesis Holdings CEO, Gary S. Gillheeney, sold shares to cover withholding taxes related to a previous stock option exercise.
Summary
- Organogenesis Holdings CEO, Gary S. Gillheeney, sold a total of 259,332 shares of Class A Common Stock between December 10 and December 12, 2024.
- The sales were executed to cover withholding taxes associated with a stock option exercise reported on December 9, 2024.
- The shares were sold in multiple transactions at varying prices, with weighted average prices of $3.64 on December 10 and 11, and $3.55 on December 12.
- The price ranges for the sales were $3.4531 to $3.74 on December 10, $3.51 to $3.72 on December 11, and $3.495 to $3.65 on December 12.
Sentiment
Score: 5
Explanation: The document describes a routine transaction, not indicative of positive or negative sentiment. It is a standard practice for executives to sell shares to cover tax obligations.
Industry Context
This is a routine transaction for executives who exercise stock options, and the sale of shares to cover taxes is a common practice.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a standard practice across publicly traded companies.
- The price ranges and weighted average prices are typical for market transactions of this nature.
- Similar transactions are regularly reported by executives at companies like Medtronic, Stryker, and Boston Scientific.
Stakeholder Impact
- The share sales may have a minor impact on the stock price, but are unlikely to cause significant fluctuations.
- The sales are a normal part of executive compensation and are not expected to affect the company's operations or financial health.
Key Dates
| Date | Description |
|---|---|
| 2024-12-09 | Date of the Form 4 filing reporting the stock option exercise that triggered the tax obligation. |
| 2024-12-10 | Date of the first sale of shares, 58,525 shares at a weighted average price of $3.64. |
| 2024-12-11 | Date of the second sale of shares, 157,448 shares at a weighted average price of $3.64. |
| 2024-12-12 | Date of the third sale of shares, 43,359 shares at a weighted average price of $3.55. |
Keywords
Organogenesis Holdings, stock sale, insider trading, CEO, Gary S. Gillheeney, Class A Common Stock, withholding tax, stock options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.